Sign in

CIK 0001178253

  • Non-accelerated filer
  • Smaller reporting company

SCYNEXIS INC

Sign in to watch
Ticker
SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
562181648
Phone
+1 201-884-5485
Business address
1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.23 ($22,300)
  6. 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $1.85 ($9,248)
  7. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.61 ($16,100)
  8. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.55 ($15,500)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Director bought 20,000 shares at $1.75 ($35,000)
  13. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $1.69 ($42,250)
  14. 4 Open-market buy Chief Medical Officer bought 15,000 shares at $1.70 ($25,500)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 16 · 314 filings